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Coronary collaterals are an alternative source of blood supply to myocardium jeopardized by ischaemia. In comparison with other species, the
human coronary collateral circulation is very well developed. Among individuals without coronary artery disease (CAD), there are preformed
collateral arteries preventing myocardial ischaemia during a brief vascular occlusion in 20–25%. Determinants of such anastomoses are low heart
rate and the absence of systemic arterial hypertension. In patients with CAD, collateral arteries preventing myocardial ischaemia during a brief
occlusion are present in every third individual. Collateral flow sufficient to prevent myocardial ischaemia during coronary occlusion amounts to
one-fifth to one-fourth the normal flow through the open vessel. Myocardial infarct size, the most important prognostic determinant after such an
event, is the product of coronary artery occlusion time, area at risk for infarction, and the inverse of collateral supply. Well-developed coronary
collateral arteries in patients with CAD mitigate myocardial infarcts and improve survival. Approximately one-fifth of patients with CAD cannot
be revascularized by percutaneous coronary intervention or coronary artery bypass grafting. Therapeutic promotion of collateral growth is a
valuable treatment strategy in those patients. It should aim at growth of large conductive collateral arteries (arteriogenesis). Potential arteriogenic
approaches include the treatment with granulocyte colony-stimulating factor, physical exercise training, and external counterpulsation.
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Introduction
If the human coronary artery tree were a system void of inter-arterial
anastomoses as stated in 1881 by Cohnheim on the basis of canine
studies,1 permanent total upstream occlusion of an epicardial
branch would invariably result in entirely necrotic downstream myo-
cardium. However, data from less historical work have indicated the
absence of myocardial infarction in every other patient with chronic
total coronary artery occlusion,2 thus providing evidence for the
functional existence of coronaryanastomoses in the presence of cor-
onary artery disease (CAD). However, in the absence of CAD, it was
not before the patho-anatomic investigations by William Fulton that
the existence of preformed human coronary collaterals was proved
beyond doubt (Figure 1).3 Function as opposed to structure of the
coronary collateral network can be defined physiologically or in
the sense of prognostic relevance: Do structural anastomoses
carry detectable flow during temporary or permanent upstream
native vessel occlusion? Is permanent coronary occlusion related
to normal or abnormal ventricular function? Are well-functioning
coronary collaterals related to improved clinical outcome?
The aim of the present article is to provide an overview of the de-
velopment and clinical importance including therapeutic inducibility
of the human coronary collateral circulation both in structural and
functional terms.
For the present article, we searched PubMed, BIOS, and ISI Web
of Science until February 2013. In addition, abstract lists and confer-
ence proceedings from the 2006 to 2012 scientific meetings of the
American College of Cardiology, the European Society of Cardi-
ology, the Symposium on Transcatheter Cardiovascular Therapeu-
tics of the American Heart Association, and the World Congress of
Cardiology were searched. We also considered published review
articles, editorials, and internet-based sources of information
(www.tctmd.com, www.theheart.org, www.europcronline.com,
www.cardiosource.com, and www.crtonline.com) to assess po-
tential information on studies of interest. Reference lists of
selected articles were reviewed for other potentially relevant cita-
tions. The search syntax for the database Medline included the
terms ‘coronary circulation’, ‘collateral circulation’, ‘anastomosis’,
‘angiogenesis’, ‘arteriogenesis’, ‘vasculogenesis’, ‘survival’, ‘prog-
nosis’, and ‘mortality’.
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Development of the human
coronary collateral circulation
Vasculogenesis occurs during the embryological development of the
circulatory system and is defined as the de novo formation of blood
vessels from endothelial precursor cells, which migrate and differen-
tiate in response to local signals. In full-term neonates, the prevalence
of coronary anastomoses as obtained in patho-anatomic studies has
been consistently high.4,5 These structural coronary collaterals found
in 80% of the newborns may be interpreted as remnants of the reti-
form, early stages of arterial development, i.e. of vasculogenesis in
embryonic life. In comparison, Zoll et al.6 found structural intercor-
onary anastomoses in 46% of 1050 post-mortem hearts from adult
patients, whereby the prevalence ranged from 9% in normal hearts
to 95% in the presence of chronic total coronary occlusion (63% in
CAD patients with marked arterial narrowing). Using a much more
refined stereo-arteriographic, i.e. vascular overlay detecting tech-
nique with bismuth-oxychloride-gelatine radiographic contrast
medium containing uniform particles sized 0.5–2.0 mm, Fulton3
found ‘numerous anastomoses in all normal hearts’ as well as in
those with heart disease (Figure 1). Fulton demonstrated a calibre in-
crease of the anastomoses from 10–200 mm in the absence of CAD
to 100–800 mm in the presence of CAD. This growth in structural
vascular size goes along with a decreasing number of collateral arter-
ies during CAD development, i.e. a process called pruning (Figure 1).
Pathophysiologically and in the sense of the Hagen Poiseuille law,
pruning may be interpreted as a way of effectively reducing vascular
resistance to collateral flow, because a large caliber increase of a
few vessels is more efficient for bulk flow augmentation than a
small increase in sizeof numerous vessels. More recently, pre-formed
arteriolar collaterals indistinguishable from normal arterioles have
been found to have a size of about 50 mm in diameter and to
consist of one to two layers of smooth muscle cells.7 The process
of arteriogenesis leads to the positive remodelling of an arteriole
intoanarteryup to12 times itsoriginal size.7 First in vivo functional cor-
onary collateral measurements during coronary bypass surgery and
percutaneous coronary intervention (PCI) have been performed
only during the 1970s.8 The existence of in vivo functional coronary
collaterals in the absence of CAD has not been proved before
2003 in a sizeable population.9 Wustmann et al.9 showed in 100
patients that collateral function in a briefly occluded, normal coron-
ary artery amounted on average to 18% of the flow through the
non-obstructed vessel (collateral flow index, CFI; Figure 2). Every
fourth individual in this population did not suffer from angina pectoris
and every fifth patient did not reveal signs of myocardial ischaemia as
obtained by intracoronary ECG during the 1-min coronary balloon
occlusion. In comparison to other species including guinea pig, dog,
cat, rat, ferret, baboon, rabbit, and pig, humans possess the most
advanced coronary collateral function behind the guinea pig, the cor-
onary artery supply of the latter is entirely replaced by collateral flow
in case of a native coronary occlusion (Figure 3).10 The following inde-
pendent determinants of a well functioning, preformed human cor-
onary collateral circulation in the absence of CAD have been
described: low heart rate (not related to beta-blockers) and
absence of arterial hypertension.11
Similar to the above described structural anastomotic calibre in-
crease in the presence of CAD,3 a shift to a more advanced coronary
collateral function has been found in response to CAD development
(Figure 4).12 There has been evidence from experimental studies that
ageing negatively affects collateral remodelling via impaired endothe-
lial nitric oxide synthase pathways and by increased oxidative stress in
coronary arterioles.13 Notwithstanding, collateral arterioles and ar-
teries do not seem to be prone to atherosclerosis.
Clinical importance of the human
coronary collateral circulation
The rightward shift of collateral function to higher CFI values with the
development of haemodynamically relevant atherosclerotic lesions
is further exemplified by the fact that patients with chronic total cor-
onary occlusion have a higher CFI in the occluded vascular area when
comparedwith patientswithout chronic occlusion: 0.365+0.190vs.
0180+ 0.105 (P, 0.0001).12 Thus, collateral function is a direct in-
dicator of CAD severity, which itself negatively influences clinical
outcome. Theoretically, the human coronary collateral function
Figure 1 Post-mortem coronary arteriograms in ‘unrolled’ hearts from an individual without cardiac disease (left) and a patient with coronary
artery disease (CAD) and two occlusions of the left main and the left-anterior descending coronary artery (red symbols). In the case with
normal heart, numerous anastomoses between the LAD and the right coronary (RCA) territory via the interventricular septum are visible.
In the presence of occlusive CAD, a few enlarged collateral arteries between the left and the right coronary artery are discernible; one of them
distal to the LAD occlusion is a branchcollateral artery between the RCAwith proximal origin and distal orifice in the LAD (). LCX, left circumflex
coronary artery.
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can, thus, be a marker of poor outcome in CAD, while having a causal
relation to favourableoutcome in thecontextof its salvagingeffecton
myocardium jeopardized by flow limiting stenoses. In the individual
patient, the myocardial salvaging effect of coronary collaterals is
well known to every interventional cardiologist. Such a case is illu-
strated on Figure 5: A 55-year-old woman who was admitted for inva-
sive cardiac examination for atypical, non-exercise-induced chest
pain revealed chronic total occlusion of the proximal left-anterior
descending (LAD) artery with entirely normal left-ventricular (LV)
systolic function. The occluded LAD was entirely filled by a branch
collateral artery extending via the LV apex and by several septal col-
lateral arteries (Figure 5). In this case, the well-developed coronary
collateral circulation served both as an indicator for the severity of
the LAD lesion and as the cause for the preservation of the anterior
wall systolic LV function. Following revascularization with stenting of
the LAD occlusion, an instantaneous fall of LAD filling with contrast
from the contralateral right coronary artery could be observed
(Figure 5). Functionally, the collateral circulation has been observed
also to decrease 24 h after of a chronic total occlusion revasculariza-
tion, and this loss in collateral function has been documented to con-
tinue 6 months after the intervention.14
Figure 6 (‘patient A’, left side) depicts the pressure-derived CFI
measurement of the above described patient with simultaneous
Figure 2 Normal coronary angiogram with collateral flow index (CFI) measurement in the left-anterior descending artery (lower panel). The
following pressures are simultaneously recorded before (left side) and during (right side) coronary artery balloon occlusion: mean and phasic
aortic, distal coronary (before and during occlusion), and central venous pressure. CFI ¼ (Poccl2CVP)/(Pao2CVP), amounting to0.35 in this case.
Figure 3 Inter-species differences in coronary collateral relative
to normal flow in the non-occluded vessel.
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recordings of aortic, distal coronary occlusive, and central venous
pressure as well as an intracoronary ECG obtained from the coron-
ary pressure guidewire. Collateral relative to normal antegrade flow
in this patient was equal to 0.76, and no ECG changes indicative of is-
chaemia were visible during coronary occlusion (Figure 6, left side). In
comparison, another patient with a CFI of 0.19 (Figure 6, ‘patient B’,
right side) revealed marked ST-segment elevation on intracoronary
ECG during vs. before coronary balloon occlusion. The intracoron-
ary ECG at a threshold of ST-segment elevation of .0.1 mV is
widely accepted as a sensitive tool for the detection of myocardial is-
chaemia.15 Accordingly, there is a second method for collateral as-
sessment during coronary balloon occlusion, which is entirely
independent of the CFI measurement, and which provides direct
qualitative (.0.1 mV present or absent) or quantitative (continuous
Figure 4 Frequency distribution of collateral flow index in patients without and in those with coronary artery disease.
Figure5 Chronic total occlusion of the proximal left-anterior descending coronary artery (arrow; LAD) with a normal left-ventricular angiogram
(upper panels). Contrast injection into the right coronary artery of the same patient shows complete retrograde filling of the LAD via a branch col-
lateral artery up to the proximal occlusion site (lower left panel). The filling disappears after percutaneous coronary intervention of the chronic LAD
occlusion (lower right panel).
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value of ECG ST elevation or depression) information on whether
collateral function is insufficient or sufficient to prevent ischaemia.
Additionally, the presence or absence of angina pectoris during a sys-
tematic 1-min coronary balloon occlusions can be employed for di-
chotomous grading of insufficient or sufficient collateral function.12
A strong inverse relation between CFI and the intracoronary occlu-
sive ECG ST-segment shift (elevation or depression) as quantified in
mV has been described.11 A sufficient CFI ≥ 0.217 can be accurately
detected using an ST-segment shift ≤0.1 mV on intracoronary
ECG.11 More importantly, absence of ECG ST-segment shift during
brief coronary occlusion in patients with chronic CAD conveys a
decreased long-term mortality.11
From canine studies16 and from clinical investigations in the setting
of acute myocardial infarction,17 it has been well known that the
degree of epicardial ECG ST-segment elevation is related to infarct
size, and that infarct size is a prognosticator for outcome, respective-
ly. A subsequent, large-scale investigation in patients with acute myo-
cardial infarction has confirmed the ECG ST-segment elevation as a
surrogate marker for outcome.18 ECG ST-segment elevation itself is
directly influenced by the duration of coronary occlusion, by the is-
chaemic area at risk, by the absence of preconditioning episodes of
myocardial ischaemia preceding the infarct, by the lack of collateral
supply to the ischaemic area, and by the level of myocardial oxygen
consumption during coronary occlusion.19 The ischaemic area at
risk and its collateral supply are intimately and inversely related as illu-
strated by Figure 5, i.e. it may become negligible in case of extended
contralateral collaterals. Also, the time of coronary occlusion may
become irrelevant with sufficient collateral supply to prevent myo-
cardial ischaemia.
In the above context, the question arises on the collective prognos-
tic relevance of a well-developed coronary collateral circulation.
Despite the fact that the coronary collateral circulation has long
been recognized as an alternative source of blood supply to a myo-
cardial area jeopardized by ischaemia, its prognostic relevance for
the population of patients with CAD has been controversial until re-
cently. The debate was in part related to different populations exam-
ined (acute vs. chronic CAD, varying severity of CAD), to the term
‘prognosis’, and to methodological issues such as the statistical
power of the investigation relative to the occurrence of study
endpoints, the duration of follow-up and the instrument employed
to measure collateral supply. For example, two recent studies have
documented a reduction in non-fatal cardiovascular events among
patients with vs. those without angiographic coronary collaterals in
chronic stable CAD.20,21 Conversely, data from the same group have
indicated anunfavourableprognosis in the presence ofwell-developed
collaterals among patients with more severe chronic CAD.22
Acute coronary artery syndrome and
clinical events in relation to collaterals:
pre-primary percutaneous coronary
intervention data
In a study by Waldecker et al.,23 angiographic collaterals to myocar-
dium distal to an acutely occluded coronary artery were detected
in 334 of 626 patients (69%) during the acute infarct phase,
whereby the prevalence was shown to increase to 75% between 3
and 6 h following symptom onset, and the absence of collaterals
was related to the early occurrence of cardiogenic shock in patients
Figure6 Left panel (same patient as in Figure 5, ‘patient A’): Simultaneous recording of mean and phasic aortic (Pao, thick line), coronary occlusive
(Poccl, red line), and central venous (CVP, thin black line) pressure for the calculation of collateral flow index, CFI. During coronary balloon occlusion,
no intracoronary ECG signs of myocardial ischaemia are visible. In comparison (right panel), ‘patient B’ shows a much lower Poccl and marked
intracoronary ECG ST-segment elevation during coronary occlusion (right side of the panel).
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with inferior myocardial infarction. Earlier investigations have
observed collateral vessels at the onsetof acute myocardial infarction
less frequently, i.e. in about 40% of patients.24 Schwartz et al.24
reported an analysis of the coronary collateral circulation in a
series of 116 post-infarction angiograms from patients with persist-
ent total occlusion of their infarct artery. Of 42 patients studied
within 6 h of infarction, about half of them had angiographic evidence
of coronary collateral development when compared with over 90%
studied 1 day to 2 weeks after infarction.24 Residual blood flow
carried by collaterals at the time of acute myocardial infarction
implies reduced infarct size and improved residual LV ejection frac-
tion.25 However, the question of whether the collateral circulation
improves clinical prognosis after acute myocardial infarction has
not been frequently investigated and the answer seems to be still con-
troversial. Considering the numerous variables influencing the rele-
vance of collateral supply in acute coronary syndrome, such as the
time window of study inclusion after symptom onset, the mode of
revascularization (none, thrombolysis, PCI), the differentiation of
preformed or subsequently grown collaterals, the mode of collateral
assessment, the debate is not unexpected.
Acute coronary artery syndrome and
clinical events in relation to collaterals:
primary percutaneous coronary
intervention data
Investigations on the prognostic effect of collaterals in patients with
successful primary PCI within the 6 h window of symptom onset
are methodologically advantageous over the above described
pre-PCI studies, because their populations are much more homoge-
neous and thus, better comparable. In a study including 238 patients
with acute myocardial infarction due to mid- or proximal LAD occlu-
sion, Pe´rez-Castellano et al.26 found a significantly higher in-hospital
mortality among patients without when compared with those with
collaterals on the angiogram obtained during primary PCI. The
study by Pe´rez-Castellano et al.26 focused on collaterals present
during the 6 h time window after symptom onset, and thus, examined
the relevance of preformed collaterals.26 The study by Antoniucci
et al.27 is comparable to that by Pe´rez-Castellano et al.,26 since
both studied the outcome in patients with acute myocardial infarc-
tion undergoing primary PCI within 6 h from symptom onset, and
the rate of angiographic collaterals in both was similar, i.e. 23%, re-
spectively, 36%. However, Antoniucci et al.’s27 work included a
much larger study population of 1164 patients who presented with
acute infarct of any territory, and the follow-up of clinical events
was registered until 6 months after initial revascularization. At 6
months, 11 out of 264 patients in the group with visible collaterals
(4%) and 80 out of 900 patients without collaterals (9%) had died
(Figure 7).27 Steg et al.28 documented in 2173 patients with subacute
myocardial infarction that the angiographic presence of coronary col-
laterals was associated with lower cumulative 60-month event rates
of death (P ¼ 0.009), class III and IV heart failure (P ¼ 0.0001), or
either (P ¼ 0.0002), but had no association with the risk of reinfarc-
tion. However, by multivariate analysis, collateral flow was neither an
independent predictor of death nor of the primary trial endpoint
(composite of death, reinfarction, or class IV heart failure). In
recent meta-analysis on the topic,29 the risk ratio to die from any
cause for high vs. low or absent collateralization in patients with
subacute myocardial infarction was 0.53 (95% confidence interval
0.15–1.92; P ¼ 0.335), and for patients with acute myocardial infarc-
tion, it was 0.63 (95% confidence interval 0.29–1.39; P ¼ 0.257).
Chronic coronary artery disease and
clinical events in relation to collaterals
Regarding the practical dilemma of the collateral circulation being
both a marker of CAD severity and a predictor of future cardiac
events, the setting of acute or chronic CAD does not make a differ-
ence. Thus in both situations, an investigation focusing on the prog-
nostic relevance of collaterals should correct for their role as
indicators for CAD severity. While in acute CAD, the collateral cir-
culation as an indicator for CAD is corrected for by primary PCI, thus
rendering the study population homogeneous with regard to the
variable stenosis severity, a similar effect can be reached in chronic
CAD by focusing exclusively on total coronary occlusions.
However, strictly speaking, chronic total occlusion with downstream
infarcted myocardium ought to be excluded from such an analysis.
Angiographic evidence of collaterals and outcome
The majority of studies on the prognostic relevance of collaterals in
chronic CAD has used angiographic assessment for characterizing
the degree of collateral perfusion. It was not before 2004 that the
topic regained heightened interest using the tool of angiographic col-
lateral qualification in relation to their prognostic relevance.20 In 281
patients randomized to off-pump or on-pump coronary artery
bypass grafting, Nathoe et al.20 found angiographic collaterals to be
present in close to 50%. Cumulative rates of event-free survival at
1 year were 87% in patients with and 69% in those without collaterals
after off-pump bypass surgery (P ¼ 0.01), and the respective figures
were 66 and 63%, respectively (P ¼ 0.79), following on-pump
surgery.20 The protective effect of collaterals in the off-pump
group appeared to be conveyed by fewer peri-operative myocardial
infarcts than in the on-pumpgroup. In an attempt tountangle the rele-
vance of the collateral circulation as a marker of CAD severity from
that as a prognostic determinant, Koerselman et al.22 performed a
case–control study in 244 patients admitted for elective PCI.
Figure 7 Cumulative survival related to all-cause mortality in
patients with and without angiographically visible collateral
vessels during percutaneous coronary intervention in the context
of acute myocardial infarction.
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Angiographic collaterals were absent in 153 and present in 91
patients, and the results indicated that in chronic CAD, the presence
of angiographic collaterals may indicate an adverse outcome, in par-
ticular, if present to a limited extent.22 The authors of that study pro-
posed that the fate of a patient is determined by the balance between
CAD severity and the presence and extent of the coronary collateral
circulation. The same research group studied the relation between
angiographic collaterals and cardiac death or myocardial infarction
at 1 year after coronary revascularization in 561 patients who were
enrolled in a randomized study that compared stent implantation
with bypass grafting.21 Collaterals were present in 176 patients
(31%). The adjusted odds ratio of cardiac death or infarction was
0.18 (95% confidence interval 0.04–0.78) in the presence of collat-
erals, and the cumulative survival free of death or infarction was
1.1% with and 5.3% without collaterals (P ¼ 0.01).21 Considering
the very low absolute numbers of cardiac death and myocardial in-
farction of 3, respectively, 4, and of 26, respectively, 21 in both
studies by Koerselman et al.22 and by Nathoe et al.,21 the opposing
conclusions are difficult to appreciate. In comparison to these under-
powered investigations, the one by Abbott et al.30 compared the
baseline characteristics and cumulative 1-year event rates of 6183
consecutive patients undergoing PCI by target vessel collateral
status. Collateral status was defined angiographically as follows:
absent (n ¼ 5051), treated artery supplied collaterals (n ¼ 239),
and treated artery received collaterals (n ¼ 893). As a major limitation
of this study, the discrimination between the absence of angiographic
collaterals to the arteryof interest andcollaterals takingoff that vessel
(i.e. supplying another artery) lacks any clear definition, and has to be
regarded as very difficult especially in the context of registry data.
Compared with the no-collaterals group, the one with PCI of a col-
lateral receiving artery had lower adjusted death/myocardial infarc-
tion rates (relative risk of 0.72, 95% CI 0.54–0.96, P ¼ 0.02) and
repeat revascularization rates (relative risk 0.73, 95% CI 0.59–0.91,
P ¼ 0.005).30 Cumulative 1-year mortality was 4.7% in the group
without and 4.1% in the group with collaterals to the vessel undergo-
ing PCI (P ¼ 0.70). Due to the unusual angiographic collateral defin-
ition, the important all-cause mortality data are difficult to interpret.
Recently, Regieli et al.31 retrospectively analysed data from a lipid
lowering trial involving 879 male participants undergoing coronary
angiography and being followed for 24 months. The rate of collaterals
spontaneously visible on angiography was assessed. Event-free sur-
vival after 2 years was 84% in patients without collaterals and 92%
in patients with collaterals (P ¼ 0.0020; events: cardiac death, myo-
cardial infarction, repeat PCI, coronary artery bypass grafting).
Despite the fact that the absolute numbers of death and myocardial
infarction were low and similar to the abovementioned figures (eight
deaths, 19 infarcts),31 the authors concluded that the ‘protec-
tive effect is independent of disease burden, and remains present
in patients with extensive CAD’.
Quantitative collateral assessment and outcome
The analysis of a database on quantitative invasive collateral assess-
ment has provided clinical and haemodynamic data of 845 individuals
(age, 62+11 years), 106 patients without CAD and 739 patients
with chronic stable CAD, who underwent a total of 1053 quantita-
tive, coronary pressure-derived collateral measurements between
March 1996 and April 2006.32 All patients have been prospectively
included in the CFI database containing information on recruitable
collateral flow parameters obtained during a 1 min coronary
balloon occlusion. Collateral flow index was calculated as described
earlier (Figures 2 and 6). In this study by Meier et al.,32 patients were
divided into groups with poorly (CFI, 0.25) or well-functioning col-
lateral vessels (CFI ≥ 0.25). Follow-up information on the occur-
rence of all-cause mortality and major adverse cardiac events after
study inclusion was collected. Cumulative 10-year survival rates
free of all-cause and cardiac deaths were 71 and 88%, respectively,
in patients with low CFI and 89 and 97% in the group with high CFI
(P ¼ 0.0395, P ¼ 0.0109) (Figure 8). Using Cox proportional
hazards analysis, the following variables independently predicted ele-
vated cardiac mortality: age, low CFI (as continuous variable), current
smoking.32 In the above-mentioned meta-analysis,29 the risk ratio
to die from any cause for high vs. low or absent collateralization in
patients with stable CAD was 0.59 (95% confidence interval
0.39–0.89), P ¼ 0.012.
Therapeutic promotion of the
human coronary collateral
circulation
In the context of a relevant prognostic effect of the coronary collat-
eral circulation among patients with CAD, the crucial question is
whether it is therapeutically promotable. Angiogenesis and arterio-
genesis as opposed to vasculogenesis are possible therapeutic strat-
egies for inducing the growth of new blood vessels.
Angiogenesis
New vessels can subsequently develop from the pre-existing plexus
by sprouting and intussusception. This formation of new vessels has
been called angiogenesis.33 In addition to endothelial cells, pericytes
and smooth muscle cells are necessary for the maturation of these
Figure 8 Cumulative survival related to all-cause mortality in
patients with chronic coronary artery disease and collateral func-
tion sufficient (collateral flow index, CFI ≥ 0.25, red line) or insuf-
ficient (CFI , 0.25, black line) to prevent myocardial ischaemia
during a brief vascular occlusion.
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newly growing vessels.33 During angiogenesis, new capillaries form
around zones of tissue ischaemia, as it occurs in myocardial infarction
and stroke.With ischaemia, growth factors such as hypoxia-inducible
factor 1a and inflammatory mediators are released locally leading to
vasodilation, enhanced vascular permeability, and accumulation of
monocytes and macrophages which in turn secrete more growth
factors and inflammatory mediators.34 These inflammatory cells
release metalloproteinases that dissolve the surrounding matrix
and the basal membrane of the preformed vessel. Hypoxia sensitizes
the local endothelial cells to the chemotactic and proliferative effects
of various growth factors by up-regulating their receptors. Endothe-
lial cells detach from their neighbours, migrate, proliferate, and sub-
sequently form a new vessel with a lumen. Pericytes and smooth
muscle cells are also involved in this process.
Although animal studies have established the principle that collat-
eral function improves after delivering angiogenic growth factors,35
and although first uncontrolled clinical studies have demonstrated
safety and feasibility of vascular endothelial growth factor and basic
fibroblast growth factor,36 efficacy of angiogenic therapy has not
been shown so far.
Arteriogenesis
Invasive cardiologists have longbeen awareof the occurrenceof large
epicardial branch or septal collateral vessels after total or subtotal oc-
clusion of a major coronary artery. These usually become visible
within several weeks following an occlusion, and they arise from pre-
formed collaterals. The remodelling process involved in this struc-
tural recruitment of already existing collateral vessels has been
termed arteriogenesis.34,37 Large bridging collaterals are physically
much more effective in salvaging ischaemic myocardium than small
peri-ischaemia capillaries. The complete obstruction of a coronary
artery leads to a fall in post-stenotic pressure and to a redistribution
of blood to pre-existing, anastomotic arterioles originating from the
non-ischaemic vascular region. The resulting longitudinal shear
forces lead to an increased expression of certain endothelial chemo-
kines, adhesion molecules, and growth factors. Within days, circulat-
ing monocytes attach to the endothelium of the bridging collateral
vessels causing a local inflammatory reaction.34 Matrix dissolution
occurs and the vessels undergo a growth process with active prolif-
eration of their endothelial and smooth muscle cells.
Arteriogenesis has been shown to be induced by activated macro-
phages,38 by lipopolysaccharide,34 monocyte chemotactic protein-1,37
tumournecrosis factor-alpha, FGF, andalsovia granulocyte-macrophage
colony-stimulating factor (recombinant human GM-CSF).39 In two
small randomized placebo-controlled clinical trials, GM-CSF has
been shown to be effective with regard to sequentially and invasively
obtained collateral function (CFI) in patients with CAD.40,41
However, GM-CSF appears to be related to atherosclerotic plaque
rupture and can, therefore, not be regarded safe in the treatment
of patients with CAD.41 Granulocyte-colony-stimulating factor
(G-CSF) has recently been shown in a controlled randomized trial
among 52 patients undergoing baseline and follow-up CFI measure-
ments to be effective in the promotion of collateral function.42
Arteriogenesis is related to enhanced tangential shear forces at the
vessel wall in response to increased flow through pre-existing collat-
eral connections. Therefore and aside from the biochemical stimula-
tion of monocytes/macrophages, physical exercise would be a
therapeutic option for inducing arteriogenesis, because cardiac
output and thus coronary flow is elevated along the arterial branches
of the coronary circulation during exercise (Table 1). So far, a pro-
spective investigation in humans on the effect of exercise regarding
collateral growth has employed an insensitive instrument for collat-
eral assessment, i.e. angiographic imaging of spontaneously visible
collateral vessels, andhasbeen negative.43 Data fromourown labora-
tory suggest that even in the absence of CAD collateral flow as
assessed by intracoronary pressure-derived measurements is aug-
mented substantially in response to endurance exercise training.44
Also, a study in CAD patients participating in a 3-month physical
exercise-based cardiac rehabilitation program has shown improved
collateral function in comparison to a sedentary control group.45
An alternative mechanism to physical exercise of applying augmen-
ted vascular shear forces is based on external counterpulsation
(ECP), which is triggered to the ECG and executed during diastole.
Recently, the first controlled trial in a group of CAD patients under-
going a 30 h program of high-pressure ECP (300 mmHg) and in a
group undergoing sham ECP at 80 mmHg inflation pressure has
revealed an unexpectedly high increase in CFI between baseline
and follow-up at 4 weeks.46
Conclusions
In conclusion, the human coronary circulation has an extensive anas-
tomotic network even in the absence of CAD. Such preformed cor-
onary collaterals are able to prevent signs of myocardial ischaemia
during a brief coronary occlusion in one-fourth of individuals, and
their function is associated with low heart rate and the absence of ar-
terial hypertension. With the development of CAD, the prevalence
of collaterals sufficient to prevent ischaemia increases to one-third,
and a well-developed coronary collateral function is related to
reduced mortality in these patients. Therapeutic promotion of cor-
onary collateral function is, thus, a promising concept, and potential
arteriogenic approaches include the treatment with G-CSF, physical
exercise training and ECP.
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small randomized trial (n ¼ 52)
Physical exercise45 No randomized data
External
counterpulsation46
One randomized controlled trial,
observational studies
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